Paroxysmal Nocturnal Hemoglobinuria and Cancer: High Incidence Of Cancer In a Large Series Of PNH Patients In a Single Center

被引：0
|
作者：
Munoz-Linares, Cristina
Ojeda, Emilio
Fores, Rafael
Cabero, Martin
Morillo, Daniel
Bautista, Guiomar
Navarro, Belen
Krsnik, Isabel
Gil, Santiago
de Lalglesia, Almodena
Regidor, Carmen
Bueno, Jose Luis
Garcia-Marco, Jose A.
Cabrera, Jose Rafael
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.4871.4871
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4871
引用
收藏
页数：1
相关论文
共 50 条
  • [21] No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab
    Alashkar, Ferras
    Rottinghaus, Scott
    Vance, Colin
    Herich-Terhuerne, Doerte
    Duehrsen, Ulrich
    Assert, Roland
    Roeth, Alexander
    PLOS ONE, 2020, 15 (03):
  • [22] Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry
    Lee, Jong Wook
    de Latour, Regis Peffault
    Brodsky, Robert A.
    Jang, Jun Ho
    Hill, Anita
    Roeth, Alexander
    Schrezenmeier, Hubert
    Wilson, Amanda
    Marantz, Jing L.
    Maciejewski, Jaroslaw P.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (01) : E37 - E41
  • [23] EFFECT OF ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS WITH OR WITHOUT HIGH DISEASE ACTIVITY: RESULTS FROM THE INTERNATIONAL PNH REGISTRY
    Hoechsmann, B.
    de Fontbrune, F. Sicre
    Lee, J. W.
    Kulagin, A.
    Hillmen, P.
    Wilson, A.
    Marantz, J.
    Schrezenmeier, H.
    HAEMATOLOGICA, 2017, 102 : 188 - 189
  • [24] High incidence of progression to chronic renal insufficiency in patients with paroxysmal nocturnal haemoglobinuria (PNH)
    Arnold, L. M.
    Hillmen, P.
    Elebute, O.
    Kelly, R. J.
    Urbano-Ispizua, A.
    Rother, R. P.
    Hill, A.
    Browne, P.
    Buchanan, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 110 - 111
  • [25] Risk factors for survival and thrombosis in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): A single institution study of 68 patients.
    Smith, SB
    Tefferi, A
    Hoyer, JD
    Wolanskyj, AP
    BLOOD, 2005, 106 (11) : 307A - 307A
  • [26] Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): An International PNH Registry Analysis
    Hill, Anita
    de Latour, Regis Peffault
    Kulasekararaj, Austin G. G.
    Griffin, Morag
    Brodsky, Robert A. A.
    Maciejewski, Jaroslaw P. P.
    Marantz, Jing L.
    Gustovic, Philippe
    Schrezenmeier, Hubert
    ACTA HAEMATOLOGICA, 2023, 146 (01) : 1 - 13
  • [27] Safety and efficacy of eculizumab with concomitant erythropoietin therapy in patients with paroxysmal nocturnal hemoglobinuria (PNH)
    Mojcik, C. F.
    Young, N. S.
    Luzzatto, L.
    Socie, G.
    Hillmen, P.
    Brodsky, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] THE EFFECT OF AN ANTIBODY TO PROPERDIN ON HEMOLYSIS OF ERYTHROCYTES FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
    HINZ, CF
    JOURNAL OF CLINICAL INVESTIGATION, 1957, 36 (06): : 900 - 900
  • [29] EVALUATION OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DISEASE BURDEN IN PATIENTS ENROLLED IN THE INTERNATIONAL PNH REGISTRY
    Urbano-Ispizua, A.
    Schrezenmeier, H.
    Brodsky, R.
    Muus, P.
    Bessler, M.
    Szer, J.
    Maciejewski, J.
    Socie, G.
    Rosse, W.
    Kanakura, Y.
    Karnell, A.
    Bedrosian, C.
    Hillmen, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 422 - 422
  • [30] PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CLINICAL FEATURES AND OUTCOME IN 124 PATIENTS EVALUATED IN A SINGLE CENTER
    Zanichelli, M.
    Moromizato, D.
    Fonseca, G.
    Suganuma, L.
    Gualandro, S.
    HAEMATOLOGICA, 2016, 101 : 584 - 584
12345